Skip to main content

Table 3 Factors associated with completed TLTBI. Univariate and multivariate analyses (n = 111)

From: Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain

 

Univariate

Analysis

Multivariate

Analysis

Variables

Crude

OR

(95% CI)

p value

Adjusted OR

(95% CI)

P value

Sex

      

   Female

1

  

1

  

   Male

1.2

(0.9-1.6)

0.244

2.1

(0.9-4.9)

0.081

Age group (years)

      

   19-29

1

  

1

  

   30-34

1.1

(0.4-2.9)

0.808

1.2

(0.3-5.1)

0.789

   35-38

1.2

(0.4-3.5)

0.702

1.4

0.4-4.5)

0.599

   39-61

3.6

(1.1-11.9)

0.035

2.9

(0.6-13.1)

0.173

HIV transmission route

      

   IDU

1

  

1

  

   MSM

1.7

(0.2-12.3)

0.606

2.0

(0.3-12.2)

0.458

   Heterosexual

3.6

(1.3-9.8)

0.010

4.6

(1.4-14.7)

0.010

   Other/Unknown

1.0

(0.1-13.7)

0.979

1.3

(0.2-7.6)

0.793

Type of TLTBI

      

   9H

1

  

1

  

   6H

0.9

(0.3-2.9)

0.861

0.6

(0.2-2.2)

0.505

   12H

0.6

(1.1-2.2)

0.423

0.6

(0.2-1.9)

0.382

   2RZ

9.6

(1.1-81.4)

0.037

8.3

(2.7-24.9)

0.000

   3RH

1.9

(0.2-21.1)

0.591

1.7

(0.1-24.2)

0.702

  1. OR: Odds ratio; CI: confidence interval
  2. TLTBI: Treatment of latent tuberculosis infection; IDU: Intravenous drug user; MSM: Men who have sex with men; H: isoniazid; R: rifampin; Z: pyrazinamide
  3. Multivariate model adjusted by hospital